Frontiers in Immunology · 2023 · 11 citations · 55 references
Life SciencesImmunologyInfectious DiseasesHost-pathogen InteractionsInflammationInnate ImmunityInflammatory SignalingInnate Immune ReceptorsInnate Immune RecognitionInnate Immune ResponseInnate Immune Signaling PathwaysToll-like ReceptorsChronic Inflammatory Disease ModelsChronic Lung InflammationRespiratory PathogenesisRespiratory Viral PathogenesisToll-like Receptor SignalingToll-like Receptor Signaling PathwaysToll-like Receptor-mediated Innate Immune ResponseToll-like Receptors In Inflammation
Respiratory syncytial virus (RSV) commonly infects the upper respiratory tract (URT) of humans, manifesting with mild cold or flu-like symptoms. However, in infants and the elderly, severe disease of the lower respiratory tract (LRT) often occurs and can develop into chronic airway disease. A better understanding of how an acute RSV infection transitions to a LRT chronic inflammatory disease is critically important to improve patient care and long-term health outcomes. To model acute and chronic phases of the disease, we infected wild-type C57BL/6 and toll-like receptor 7 knockout (TLR7 KO) mice with RSV and temporally assessed nasal, airway and lung inflammation for up to 42 days post-infection. We show that TLR7 reduced viral titers in the URT during acute infection but promoted pronounced pathogenic and chronic airway inflammation and hyperreactivity in the LRT. This study defines a hitherto unappreciated molecular mechanism of lower respiratory pathogenesis to RSV, highlighting the potential of TLR7 modulation to constrain RSV pathology to the URT.
55